About
Apneal is a health technology company focused on developing an AI-based mobile application for screening and diagnosing obstructive sleep apnea (OSA) and other sleep-related breathing disorders. Their flagship product, also named Apneal, turns a smartphone into a medical-grade sleep examination device. It utilizes the phone's built-in sensors to record vital data during sleep, which is then analyzed by proprietary AI algorithms to detect cardio-respiratory events and estimate the apnea-hypopnea index (AHI). The Apneal solution is user-friendly, cost-effective, and non-invasive, requiring no additional hardware. The screening process can be completed at home in about 24 hours, enhancing patient convenience. Apneal provides first-level screening, interpretable reports for healthcare professionals, and tools for treatment follow-up. The company is working towards bringing Apneal to market as a Class IIa software medical device, aiming for CE marking and reimbursement in Europe, while conducting a multi-center clinical study to gather compliance evidence. Apneal targets healthcare professionals and decision-makers, offering a reliable solution for managing sleep disorders and improving patient outcomes.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2021
Location
Paris, Ile-de-France, France